611 reports of this reaction
12.0% of all RUFINAMIDE reports
#1 most reported adverse reaction
SEIZURE is the #1 most commonly reported adverse reaction for RUFINAMIDE, manufactured by Eisai Inc.. There are 611 FDA adverse event reports linking RUFINAMIDE to SEIZURE. This represents approximately 12.0% of all 5,100 adverse event reports for this drug.
Patients taking RUFINAMIDE who experience seizure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEIZURE is a frequently reported adverse event for RUFINAMIDE, accounting for a significant proportion of all reports.
In addition to seizure, the following adverse reactions have been reported for RUFINAMIDE:
The following drugs have also been linked to seizure in FDA adverse event reports:
SEIZURE has been reported as an adverse event in 611 FDA reports for RUFINAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEIZURE accounts for approximately 12.0% of all adverse event reports for RUFINAMIDE, making it one of the most commonly reported side effect.
If you experience seizure while taking RUFINAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.